View Older Stories View More Recent Stories

Jan 2, 2024 04:49PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 1, 2023 05:39PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 9, 2023 07:00AM Zentalis to Participate in Investor Call Focused on Ovarian Cancer with Gynecologic Oncology Key Opinion Leader Joyce F. Liu, M.D., MPH, Hosted by TD Cowen
Nov 6, 2023 07:18AM Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
Nov 1, 2023 04:52PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2023 04:27PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 6, 2023 07:00AM Zentalis Pharmaceuticals to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Sep 1, 2023 04:37PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 9, 2023 07:00AM Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
Aug 1, 2023 04:28PM Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aug 1, 2023 07:00AM Zentalis Pharmaceuticals (ZNTL) Appoints Kimberly Freeman as Chief Strategy Officer
Aug 1, 2023 07:00AM Zentalis Pharmaceuticals Appoints Kimberly Freeman as Chief Strategy Officer
Jun 6, 2023 06:03AM Zentalis Pharmaceuticals (ZNTL) Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
Jun 6, 2023 06:00AM Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
May 25, 2023 05:39PM Zentalis Pharmaceuticals (ZNTL) Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination with Chemotherapy
May 25, 2023 05:38PM Zentalis Announces Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination with Chemotherapy at the 2023 ASCO Annual Meeting
May 23, 2023 07:00AM Zentalis to Host Investor Call to Provide Clinical Update with Safety, Pharmacology, and Efficacy Results for Azenosertib Monotherapy and Development Plans for Monotherapy and Chemotherapy Combination
May 10, 2023 07:00AM Zentalis Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
Apr 26, 2023 10:00AM Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including clinical support for Cyclin E1 expression as predictive marker for clinical benefit from
Apr 17, 2023 09:03AM Zentalis Pharmaceuticals (ZNTL) Announces Preclinical Data Supporting Cyclin E1 As A Predictive Marker For Azenosertib Treatment At AACR
Apr 17, 2023 09:00AM Zentalis Announces Preclinical Data Supporting Cyclin E1 As A Predictive Marker For Azenosertib Treatment At AACR Annual Meeting 2023
Mar 1, 2023 07:00AM Zentalis Pharmaceuticals Reports Full Year 2022 Financial Results and Operational Updates
Feb 13, 2023 07:04AM Zentalis Pharmaceuticals (ZNTL) Appoints Iris Roth as COO
Feb 13, 2023 07:00AM Zentalis Pharmaceuticals Appoints Dr. Iris Roth as Chief Operating Officer
Feb 1, 2023 05:00PM Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Feb 1, 2023 07:01AM Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
Jan 3, 2023 05:00PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 1, 2022 05:00PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 9, 2022 07:00AM Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
Nov 8, 2022 07:01AM Zentalis Pharmaceuticals to Participate in the Stifel 2022 Healthcare Conference
Nov 1, 2022 05:38PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 24, 2022 07:02AM Zentalis Pharmaceuticals (ZNTL) Announces First ZN-c3 Clinical Development Collaboration with Pfizer (PFE)
Oct 24, 2022 07:00AM Zentalis Pharmaceuticals Announces First ZN-c3 Clinical Development Collaboration with Pfizer
Oct 17, 2022 07:00AM Zentalis Pharmaceuticals Appoints Dr. Mark Lackner as Chief Translational Officer, Head of Biomarker Strategy
Oct 3, 2022 05:32PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 27, 2022 04:01PM Zentalis Pharmaceuticals (ZNTL) Promotes Co-Founder Kevin Bunker, Ph.D. to Chief Scientific Officer
Sep 27, 2022 04:01PM Zentalis Pharmaceuticals Promotes Co-Founder Kevin Bunker, Ph.D. to Chief Scientific Officer
Sep 19, 2022 07:03AM Zentalis Pharmaceuticals (ZNTL) Appoints Carrie Brownstein as Chief Medical Officer
Sep 19, 2022 07:00AM Zentalis Pharmaceuticals Appoints Dr. Carrie Brownstein as Chief Medical Officer
Sep 12, 2022 07:01AM Zentalis Pharmaceuticals (ZNTL) Appoints Jan Skvarka to its Board
Sep 12, 2022 07:00AM Zentalis Pharmaceuticals Appoints Dr. Jan Skvarka to its Board of Directors
Sep 1, 2022 05:00PM Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aug 31, 2022 07:00AM Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
Aug 9, 2022 04:01PM Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
Aug 3, 2022 07:00AM Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Conference
Aug 1, 2022 05:10PM Zentalis Pharmaceuticals, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jun 27, 2022 07:11AM Zentalis Pharmaceuticals (ZNTL) Names Andrea Paul as General Counsel as Alexis Pinto Resigns
Jun 27, 2022 07:00AM Zentalis Pharmaceuticals Appoints Andrea Paul as General Counsel and Corporate Secretary
Jun 1, 2022 07:00AM Zentalis Pharmaceuticals to Participate in the Jefferies Healthcare Conference
May 31, 2022 07:07AM Zentalis Pharmaceuticals (ZNTL) Promotes Cofounder Cam Gallagher to President
View More Recent Stories View Older Stories